Quantum Biology DAO

Quantum Biology DAO

Live
Bio Curated
DAO
Quantum Biology

The Quantum Biology DAO accelerates the quantum biology field through community building, open governance, scientific experimentation, research grants, and IP development. Together we will understand and manipulate biology at the quantum level.

...
Community Size
...
Growth Rate
$QBIO
SOL
Powered by TradingView & GeckoTerminal
Market Details
Lock
Staking Available

Quantum biology unlocks a fundamentally new way to actuate on biology. Understanding the possible quantum-driven behaviors of biological systems could aid in treating injuries or in developing cures for diseases.

100+

Number of potential therapies that could arise from the deterministic control of weak magnetic fields

$1b+

Market cap of existing companies that use weak magnetic fields without knowing how they work

$0.00

Number of $ spent on Quantum Biology each year by NSF and NIH

Project

Additional Documentation

Litepaper

Weak magnetic fields influence biological cells and there is strong circumstantial evidence that the mechanism is quantum. Quantum consciousness will have to come later; the actual quantum story is that by understanding the physics behind weak magnetic field effects, it will become possible to deterministically impact the entire machinery of the cell, from oxidation rates to cellular repair to cell division rates and more.


The Quantum Bio DAO is partnered with the Quantum Biology Institute, a US non-profit that is building the quantum microscopes needed to first, definitively prove that weak magnetic field effects are a result of quantum phenomena, and second, unlock an entire new industry that takes advantage of the quantum-to-biology link. The main expected applications are in health and longevity, biomanufacturing, and drug discovery.

Clarice D. Aiello, CSO

Clarice is a quantum engineer interested in how quantum physics informs biology at the nanoscale. Born and raised in Brazil, Clarice obtained a Diplome d'Ingenieur in Physics from the Ecole Polytechnique in France and an M.Phil. in Physics from the University of Cambridge, Trinity College, in England; she received her Ph.D. from MIT in Electrical Engineering. She further held postdoctoral appointments in Bioengineering at Stanford, and in Chemistry at Berkeley.

Geoff Anders, CEO

Geoff Anders is the founder and CEO of Leverage, a research institute established in 2011 to support revolutionary scientific research. With a background in philosophy and social science, he leads Leverage’s internal research and helps external research teams organize to make important scientific breakthroughs. His recent work focuses on the intersection of philosophy, science, and history, as it pertains especially to introspection, cognitive science, and artificial intelligence. Geoff is now the CEO of the Quantum Biology Institute and holds a PhD in Philosophy from Rutgers University and a BS in Economics from the Wharton School at the University of Pennsylvania.

Alessandro Lodesani, COO

Alessandro Lodesani is the Institute's Chief Operating Officer, overseeing its daily research operations. With a strong background in physics and engineering, combined with extensive experience in biology research, Alessandro focuses on designing innovative devices and optimizing lab processes. Originally from Italy, Alessandro earned a Bachelor's in Mechanical Engineering and a PhD in Physics, graduating with honors from the Polytechnic University of Milan, with a specialization in spintronics and molecular interfaces. His previous research at MIT focused on topological qubits and superconducting thin films, where he successfully developed the world's most efficient superconducting diode platform. Alessandro then joined the Institute in its early days at UCLA, where he led several projects investigating the influence of weak magnetic fields on biological systems.

Updates

Feed
...

Stay up to date

Get the latest community updates and find out about upcoming Quantum Biology DAO developments